So long, Maybelline!

Read this post taken from Leslie Baumann, MD regarding recent FDA approval for an eyelash drug:

"A while back, I told you about a controversy that had been brewing in the dermatological world: Several cosmetic companies -- after discovering that glaucoma drugs that include ingredients known as prostaglandins had the surprising side effect of creating thicker, longer eyelashes -- began including prostaglandin-like ingredients in cosmetic products. Trouble is, the FDA had not verified or approved the assertion that such ingredients lengthen lashes, which forced cosmetics companies to retract the claim and reformulate their products.

Well, I'm pleased to share the latest update on this topic: On December 26, 2008, the drug company Allergan announced that the FDA had approved Latisse 0.03% as a treatment for hypotrichosis (the medical term for sparse eyelashes. The active ingredient in Latisse, bimatoprost, was approved for the treatment of eye disorders like glaucoma years ago, but this is the first time it has been officially approved to enhance the eyelashes (defined here as an increase in length, thickness, and darkness).
According to Allergan, applied once daily to the upper lash line (this product should not be used on the lower lashes), Latisse typically produces noticeable results in 8 weeks, with full results in 16 weeks. You'll need to keep using it to maintain those results, though -- once use is discontinued, lashes begin to return to their original state. Latisse will be sold by prescription only, and is expected to be available to consumers in the first quarter of 2009. The suggested retail price for a 30-day supply is $120 (including 60 single-use sterile applicators).

In studies, subjects tolerated Latisse well -- the primary reported side effects were eye redness or itchiness and darkening of the eyelids. Anyone considering using this, or any drug should discuss the specifics of their medical history (particularly if they are already taking the glaucoma drug Lumigan) with their doctor."